This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin. 2005; 55(2): 74-108.ParkinDMBrayFFerlayJPisaniPGlobal cancer statisticsCA Cancer J Clin20055527410810.3322/canjclin.49.1.33Search in Google Scholar
Boonkitticharoen V, Kulapaditharom B, Leopairut J, Kraiphibul P, Larbcharoensub N, Cheewaruangroj W, et al. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2008; 134(12): 1305-1311.BoonkitticharoenVKulapaditharomBLeopairutJKraiphibulPLarbcharoensubNCheewaruangrojWet alVascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinomaArch Otolaryngol Head Neck Surg2008134121305131110.1001/archotol.134.12.1305Search in Google Scholar
Eleftheriadou A, Chalastras T, Ferekidou E, Yio-takis I, Kyriou L, Tzagarakis M, et al. Association between squamous cell carcinoma of the head and neck and serum folate and homocysteine. Anticancer Res. 2006; 26(3B): 2345-2348.EleftheriadouAChalastrasTFerekidouEYio-takisIKyriouLTzagarakisMet alAssociation between squamous cell carcinoma of the head and neck and serum folate and homocysteineAnticancer Res2006263B23452348Search in Google Scholar
Lo AK, Lo KW, Tsao SW, Wong HL, Hui JW, To KF, et al. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia. 2006; 8(3): 173-180.LoAKLoKWTsaoSWWongHLHuiJWToKFet alEpstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cellsNeoplasia20068317318010.1593/neo.05625Search in Google Scholar
Hennessey PT, Westra WH, Califano JA. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res. 2009; 88(4): 300-306.HennesseyPTWestraWHCalifanoJAHuman papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implicationsJ Dent Res200988430030610.1177/0022034509333371Search in Google Scholar
Weber BL. Cancer genomics. Cancer Cell. 2002; 1(1): 37-47.WeberBLCancer genomicsCancer Cell200211374710.1016/S1535-6108(02)00026-0Search in Google Scholar
Ha PK, Chang SS, Glazer CA, Califano JA, Sidran-sky D. Molecular techniques and genetic alterations in head and neck cancer. Oral Oncol. 2009; 45(4-5): 335-339.HaPKChangSSGlazerCACalifanoJASidran-skyDMolecular techniques and genetic alterations in head and neck cancerOral Oncol2009454-533533910.1016/j.oraloncology.2008.05.015270224118674960Search in Google Scholar
Cassidy LD, Venkitaraman AR. Genome instability mechanisms and the structure of cancer genomes. Curr Opin Genet Dev. 2012; 22(1): 10-13.CassidyLDVenkitaramanARGenome instability mechanisms and the structure of cancer genomesCurr Opin Genet Dev2012221101310.1016/j.gde.2012.02.00322366532Search in Google Scholar
Viet CT, Schmidt BL. Understanding oral cancer in the genome era. Head Neck. 2010; 32(9): 1246-1268.VietCTSchmidtBLUnderstanding oral cancer in the genome eraHead Neck20103291246126810.1002/hed.2135820187013Search in Google Scholar
Agrawal N, Frederick MJ, Pickering CR, Bette-gowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011; 333(6046): 1154-1157.AgrawalNFrederickMJPickeringCRBette-gowdaCChangKLiRJet alExome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1Science201133360461154115710.1126/science.1206923316298621798897Search in Google Scholar
Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333(6046): 1157-1160.StranskyNEgloffAMTwardADKosticADCibulskisKSivachenkoAet alThe mutational landscape of head and neck squamous cell carcinomaScience201133360461157116010.1126/science.1208130341521721798893Search in Google Scholar
Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol. 2006; 24(25): 4170-4176.ChungCHElyKMcGavranLVarella-GarciaMParkerJParkerNet alIncreased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomasJ Clin Oncol200624254170417610.1200/JCO.2006.07.2587Search in Google Scholar
Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005; 5(5): 341-354.HynesNELaneHAERBB receptors and cancer: the complexity of targeted inhibitorsNat Rev Cancer20055534135410.1038/nrc1609Search in Google Scholar
Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2010; 11(1): 9-22.LeemansCRBraakhuisBJBrakenhoffRHThe molecular biology of head and neck cancerNat Rev Cancer201011192210.1038/nrc2982Search in Google Scholar
Kanai Y, Hirohashi S. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from precancerous to malignant state. Carcinogenesis. 2007; 28(12): 2434-2442.KanaiYHirohashiSAlterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from precancerous to malignant stateCarcinogenesis200728122434244210.1093/carcin/bgm206Search in Google Scholar
Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3(6): 415-428.JonesPABaylinSBThe fundamental role of epigenetic events in cancerNat Rev Genet20023641542810.1038/nrg816Search in Google Scholar
Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer. 2005; 5(3): 223-231.UshijimaTDetection and interpretation of altered methylation patterns in cancer cellsNat Rev Cancer20055322323110.1038/nrc1571Search in Google Scholar
Baylin SB, Ohm JE. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006; 6(2): 107-116.BaylinSBOhmJEEpigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?Nat Rev Cancer20066210711610.1038/nrc1799Search in Google Scholar
Lee S, Kim WH, Jung HY, Yang MH, Kang GH. Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. Am J Pathol. 2002; 161(3): 1015-1022.LeeSKimWHJungHYYangMHKangGHAberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinomaAm J Pathol200216131015102210.1016/S0002-9440(10)64262-9Search in Google Scholar
Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene. 2002; 21(27): 4231-4236.HasegawaMNelsonHHPetersERingstromEPosnerMKelseyKTPatterns of gene promoter methylation in squamous cell cancer of the head and neckOncogene200221274231423610.1038/sj.onc.120552812082610Search in Google Scholar
Loyo M, Brait M, Kim MS, Ostrow KL, Jie CC, Chuang AY, et al. A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma. Int J Cancer. 2011; 128(6): 1393-1403.LoyoMBraitMKimMSOstrowKLJieCCChuangAYet alA survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinomaInt J Cancer201112861393140310.1002/ijc.25443295515520473931Search in Google Scholar
Dikshit RP, Gillio-Tos A, Brennan P, De Marco L, Fiano V, Martinez-Peñuela JM, et al. Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer. 2007; 110(8): 1745-1751.DikshitRPGillio-TosABrennanPDeMarco LFianoVMartinez-PeñuelaJMet alHypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancersCancer200711081745175110.1002/cncr.2297517786935Search in Google Scholar
Poage GM, Christensen BC, Houseman EA, Mc-Clean MD, Wiencke JK, Posner MR, et al. Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted. PLoS One. 2010; 5(3): e9651.PoageGMChristensenBCHousemanEAMc-CleanMDWienckeJKPosnerMRet alGenetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targetedPLoS One201053e965110.1371/journal.pone.0009651283637020300172Search in Google Scholar
Sanchez-Cespedes M, Esteller M, Wu L, Yoo GH, Koch WM, Jen J, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 2000; 60(4): 892-895.Sanchez-CespedesMEstellerMWuLYooGHKochWMJenJet alGene promoter hypermethylation in tumors and serum of head and neck cancer patientsCancer Res2000604892895Search in Google Scholar
Ogi K, Toyota M, Ohe-Toyota M, Tanaka N, Noguchi M, Sonoda T, et al. Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res. 2002; 8(10): 3164-3171.OgiKToyotaMOhe-ToyotaMTanakaNNoguchiMSonodaTet alAberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinomaClin Cancer Res200281031643171Search in Google Scholar
Saloura V, Vougiouklakis T, Zewde M, Deng X, Kiyotani K, Park J-H, et al. WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer. Sci Rep. 2017; 7: 40664.SalouraVVougiouklakisTZewdeMDengXKiyotaniKParkJ-Het alWHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancerSci Rep201774066410.1158/1538-7445.AM2017-342Search in Google Scholar
Liao H-W, Hsu J-M, Xia W, Wang H-L, Wang Y-N, Chang W-C, et al. PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response. J Clin Invest. 2015; 125(12): 4529-4543.LiaoH-WHsuJ-MXiaWWangH-LWangY-NChangW-Cet alPRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab responseJ Clin Invest2015125124529454310.1172/JCI82826466578226571401Search in Google Scholar
Stein RA. Epigenetics-the link between infectious diseases and cancer. JAMA. 2011; 305(14): 14841485.SteinRAEpigenetics-the link between infectious diseases and cancerJAMA2011305141484148510.1001/jama.2011.44621486982Search in Google Scholar
Nagothu KK, Rishi AK, Jaszewski R, Kucuk O, Majumdar APN. Folic acid- mediated inhibition of serum-induced activation of EGFR promoter in colon cancer cells. Am J Physiol Gastrointest Liver Physiol. 2004; 287(3): G541-G546.NagothuKKRishiAKJaszewskiRKucukOMajumdarAPNFolic acid- mediated inhibition of serum-induced activation of EGFR promoter in colon cancer cellsAm J Physiol Gastrointest Liver Physiol20042873G541G54610.1152/ajpgi.00365.200315075253Search in Google Scholar
Langevin SM, Koestler DC, Christensen BC, Butler RA, Wiencke JK, Nelson HH, et al. Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: An epigenome-wide association study. Epigenetics. 2012; 7(3): 291-299.LangevinSMKoestlerDCChristensenBCButlerRAWienckeJKNelsonHHet alPeripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: An epigenome-wide association studyEpigenetics20127329129910.4161/epi.7.3.19134333595222430805Search in Google Scholar
Rosas SL, Koch W, Costa Carvalho MG, Wu L, Califano J, Westra W, et al. Promoter hypermethylation patterns of p16 O-6-methylguanine-DNA methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001; 61(3): 939-942.RosasSLKochWCostaCarvalho MGWuLCalifanoJWestraWet alPromoter hypermethylation patterns of p16 O-6-methylguanine-DNA methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patientsCancer Res2001613939942Search in Google Scholar
Nagase H, Ghosh S. Epigenetics: differential DNA methylation in mammalian somatic tissues. FEBS J. 2008; 275(8): 1617-1623.NagaseHGhoshSEpigenetics: differential DNA methylation in mammalian somatic tissuesFEBS J200827581617162310.1111/j.1742-4658.2008.06330.x18331347Search in Google Scholar
Costello JF, Frushwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, et al. Aberrant CpG-island methylation has non-random and tumor-type-specific patterns. Nat Genet. 2000; 24(2): 132-138.CostelloJFFrushwaldMCSmiragliaDJRushLJRobertsonGPGaoXet alAberrant CpG-island methylation has non-random and tumor-type-specific patternsNat Genet200024213213810.1038/7278510655057Search in Google Scholar
Goldenberg D, Harden S, Masayesva BG, Ha P, Benoit N, Westra WH, et al. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004; 130(1): 39-44.GoldenbergDHardenSMasayesvaBGHaPBenoitNWestraWHet alIntraoperative molecular margin analysis in head and neck cancerArch Otolaryngol Head Neck Surg20041301394410.1001/archotol.130.1.3914732766Search in Google Scholar
Zvonko M, Supić G, Branković-Magić M, Jović N. DNA methylation in the pathogenesis of head and neck cancer. In: Dricu A, editor. Methylation – From DNA, RNA and Histones to Diseases and Treatment. London, UK: InTech. 2012: 185-216. doi: 10.5772/51169.ZvonkoMSupićGBranković-MagićMJovićNDNA methylation in the pathogenesis of head and neck cancer. In: Dricu A, editor. Methylation – From DNA, RNA and Histones to Diseases and TreatmentLondon, UKInTech201218521610.5772/51169Open DOISearch in Google Scholar
Arantes LMRB, de Carvalho AC, Melendez ME, Carvalho AL, Goloni-Bertollo EM. Methylation as a biomarker for head and neck cancer. Oral Oncol. 2014; 50(6): 587-592.ArantesLMRBdeCarvalho ACMelendezMECarvalhoALGoloni-BertolloEMMethylation as a biomarker for head and neck cancerOral Oncol201450658759210.1016/j.oraloncology.2014.02.01524656975Search in Google Scholar
Freedman L. Quantitative science methods for bio-marker validation in chemoprevention trials. Cancer Biomark. 2007; 3(3): 135-140.FreedmanLQuantitative science methods for bio-marker validation in chemoprevention trialsCancer Biomark20073313514010.3233/CBM-2007-3304Search in Google Scholar
Maiti GP, Mondal P, Mukherjee N, Ghosh A, Ghosh S, Dey S, et al. Overexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genes. PLoS One. 2013; 8(5): e63440.MaitiGPMondalPMukherjeeNGhoshAGhoshSDeySet alOverexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genesPLoS One201385e6344010.1371/journal.pone.0063440365113623675485Search in Google Scholar
de Vos L, Gevensleben H, Schröck A, Franzen A, Kristiansen G, Bootz F, et al. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients. Clin Epigenet. 2017; 9: 125.deVos LGevenslebenHSchröckAFranzenAKristiansenGBootzFet alComparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patientsClin Epigenet2017912510.1186/s13148-017-0425-4570991829213339Search in Google Scholar
Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, et al. Epigenotyping in peripheral blood cell DNA and breast cancer risk: A proof of principle study. PLoS One. 2008; 3(7): e2656.WidschwendterMApostolidouSRaumERothenbacherDFieglHMenonUet alEpigenotyping in peripheral blood cell DNA and breast cancer risk: A proof of principle studyPLoS One200837e265610.1371/journal.pone.0002656244216818628976Search in Google Scholar
Pedersen KS, Bamlet WR, Oberg AL, de Andrade M, Matsumoto ME, Tang H, et al. Leukocyte DNA meth-ylation signature differentiates pancreatic cancer patients from healthy controls. PLoS One. 2011; 6(3): 18223.PedersenKSBamletWRObergALdeAndrade MMatsumotoMETangHet alLeukocyte DNA meth-ylation signature differentiates pancreatic cancer patients from healthy controlsPLoS One2011631822310.1371/journal.pone.0018223306380221455317Search in Google Scholar
Marsit CJ, Koestler DC, Christensen BC, Karagas MR, Houseman EA, Kelsey KT. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. J Clin Oncol. 2011; 29(9): 1133-1139.MarsitCJKoestlerDCChristensenBCKaragasMRHousemanEAKelseyKTDNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancerJ Clin Oncol20112991133113910.1200/JCO.2010.31.3577308386821343564Search in Google Scholar
Pulling LC, Divine KK, Klinge DM, Gilliland FD, Kang T, Schwartz AG, et al. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression. Cancer Res. 2003; 63(16): 4842-4848.PullingLCDivineKKKlingeDMGillilandFDKangTSchwartzAGet alPromoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progressionCancer Res2003631648424848Search in Google Scholar
Liu Y, Lan Q, Siegfried JM, Luketich JD, Keohavong P. Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia. 2006; 8(1): 46-51.LiuYLanQSiegfriedJMLuketichJDKeohavongPAberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patientsNeoplasia200681465110.1593/neo.05586158428916533425Search in Google Scholar
Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994; 7(4): 536-540.IssaJPOttavianoYLCelanoPHamiltonSRDavidsonNEBaylinSBMethylation of the oestrogen receptor CpG island links ageing and neoplasia in human colonNat Genet19947453654010.1038/ng0894-5367951326Search in Google Scholar
Montero AJ, Diaz-Montero CM, Mao L, Youssef EM, Estecio M, Shen L, et al. Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer. Cancer Biol Ther. 2006; 5(11): 1494-1501.MonteroAJDiaz-MonteroCMMaoLYoussefEMEstecioMShenLet alEpigenetic inactivation of EGFR by CpG island hypermethylation in cancerCancer Biol Ther20065111494150110.4161/cbt.5.11.329917369752Search in Google Scholar
